Entering text into the input field will update the search result below

Syros Pharmaceuticals misses by $0.09, misses on revenue

  • Syros Pharmaceuticals (NASDAQ:SYRS): Q1 EPS of -$0.48 misses by $0.09.
  • Revenue of $0.37M (-66.4% Y/Y) misses by $3.68M.
  • Press Release

Recommended For You

More Trending News

About SYRS Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
SYRS--
Syros Pharmaceuticals, Inc.